Potentials of ribosomopathy gene as pharmaceutical targets for cancer treatment

Potentials of ribosomopathy gene as pharmaceutical targets for cancer treatment

Ribosomopathies encompass a spectrum of disorders arising from impaired ribosome biogenesis and reduced functionality. Mutation or dysexpression of the genes that disturb any finely regulated steps of ribosome biogenesis can result in different types of ribosomopathies in clinic, collectively known...

Full description

Bibliographic Details
Main Authors: Mengxin Wang, Stephen Vulcano, Changlu Xu, Renjian Xie, Weijie Peng, Jie Wang, Qiaojun Liu, Lee Jia, Zhi Li, Yumei Li
Format: Article
Language:English
Published: Elsevier 2024-03-01
Series:Journal of Pharmaceutical Analysis
Subjects:
Ribosome biogenesis
Ribosomopathy gene
Cancer treatment target
Pharmaceutical target
Online Access:http://www.sciencedirect.com/science/article/pii/S2095177923002599

Internet

http://www.sciencedirect.com/science/article/pii/S2095177923002599

Similar Items